Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report

Figure 2 Abdominal contrast-enhanced computed tomography. A: Before treatment; B: After two cycles of hepatic artery infusion chemotherapy; C: After four cycles of hepatic artery infusion chemotherapy; D: After three cycles of atezolizumab-bevacizumab; E: After five cycles of atezolizumab-bevacizumab.